Physiological and electrophysiological consequences of etoposide-induced blood-brain barrier disruption.
The present study investigates the effects of etoposide-induced blood-brain barrier (BBB) disruption on systemic blood pressure (SBP), intracranial pressure (ICP), and electroencephalographic (EEG) activity. A total of 29 rats were divided into two groups. In Group 1, 8 control animals received intracarotid normal saline; in Group 2, 21 animals received intracarotid etoposide. SBP, ICP, and EEG were monitored continuously under general anesthesia and controlled ventilation after tracheostomy. Intravenous Evans blue dye was used for determination of BBB disruption. Although none of the Group 1 animals showed BBB disruption, 57% of the animals in Group 2 showed marked BBB disruption (3+). A slight but statistically significant increase in ICP was noted in the Group 2 animals with 3+ BBB disruption, although lesser degrees of barrier disruption (1+ or 2+) resulted in no significant alteration in ICP. The amplitude and frequency of the EEG decreased significantly ipsilateral to the side of intracarotid infusion in all animals with 3+ barrier disruption with a tendency to return toward normal within 2 hours. The degree of transient EEG change observed correlates well with the degree of barrier disruption, potentially allowing clinical determination of BBB disruption by this method.
P H
PH
Hollis
R A
RA
Zappulla
M K
MK
Spigelman
E J
EJ
Feuer
J
J
Johnson
J F
JF
Holland
L I
LI
Malis
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001812:Blood-Brain Barrier / Q000187:drug effects*; D001921:Brain / Q000502:physiology*; D004569:Electroencephalography; D004594:Electrophysiology; D005047:Etoposide / Q000494:pharmacology*; D005260:Female; D007427:Intracranial Pressure / Q000187:drug effects; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D051381:Rats; D011919:Rats, Inbred Strains
D005047:Etoposide; D011034:Podophyllotoxin